| 标题 |
Efficacy and safety of pembrolizumab, lenvatinib, and reduced-dose gemcitabine/oxaliplatin as initial treatment for advanced biliary tract cancer: a multicenter, single-arm, prospective, phase II study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal for ImmunoTherapy of Cancer 作者:Mingjian Piao; Chengjie Li; Shuofeng Li; Nan Zhang; Jiongyuan Li; et al 出版日期:2026 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)